Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trialsBirgit Sawitzki, Tewfik Miloud, Manuela Battaglia et al.|The Lancet|2020Cited by 445
COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaborationLuuk B. Hilbrands, Elena Zakharova, Raphaël Duivenvoorden et al.|Nephrology Dialysis Transplantation|2020Cited by 411
COVID-19-related mortality in kidney transplant and haemodialysis patients: a comparative, prospective registry-based studyÉric Goffin, Guy Rostoker, Alexandre Candellier et al.|Nephrology Dialysis Transplantation|2021Cited by 83
Rationale and design of the Renal Lifecycle trial assessing the effect of dapagliflozin on cardiorenal outcomes in severe chronic kidney diseaseW Bakker, J W Rood, Hiddo J.L. Heerspink et al.|Nephrology Dialysis Transplantation|2025Cited by 18